ABY-029
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ABY-029, covering 2024-12-13 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: ABY-029 Glioma Trial [Phase 1]
3 regulatory and trial events tracked for ABY-029, covering 2024-12-13 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: ABY-029 Glioma Trial [Phase 1]